American Indian and Alaska Native (AI/AN) communities experienced disproportionately severe COVID-19 outcomes, underscoring the importance of accessible testing. To understand barriers to COVID-19 testing among urban AI/AN peoples, we surveyed 788 patients from five geographically dispersed Tribal healthcare organizations between January and May 2021. Participants completed questionnaires assessing healthcare access and concerns about barriers to COVID-19 testing, as well as social determinants of health including age, gender, relationship status, education, and income. The most commonly reported concern was contracting COVID-19 during clinic visits, with 43% of respondents expressing this concern. Difficulty reaching the clinic during business hours and difficulty traveling to the clinic were reported by 20% and 14% of participants, respectively, while 19% expressed concern about the cost of testing. Higher income was associated with lower levels of concern across all four barriers. These results suggest that healthcare organizations serving AI/AN populations should proactively address concerns about infection risk during testing appointments, both for COVID-19 and for future infectious disease outbreaks. Our results also underscore the value of at-home testing, particularly when provided free of charge, as it directly addresses all barriers to in-person testing assessed in this study and may inform testing strategies in future infectious disease outbreaks.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: